ASHG Annual Meeting Know Before You Go
Includes a Live Web Event on 10/22/2024 at 1:00 PM (EDT)
-
Register
- Regular Member - Free!
- Early Career Member - Free!
- Resident/Clinical Fellow Member - Free!
- Postdoctoral Fellow Member - Free!
- Graduate Student Member - Free!
- Undergraduate Student Member - Free!
- Emeritus Member - Free!
- Life Member - Free!
- Trainee Member - Free!
- Nonmember - Free!
Hear from ASHG volunteers on how to navigate the Annual Meeting as a first-time attendee or trainee. We will cover a range of topics, from badge pick-up to networking opportunities and how to make the most of your experience. You will also have the opportunity to ask your questions during a Q&A period.
Overview of Event
- Summarize helpful tips and tricks for ASHG Annual Meeting attendees, especially those who are first-time attendees.
- Identify programming and networking opportunities for ASHG Annual Meeting attendees.
Helpful Resources
- First Time Attendees Guide
- Schedule and Online Planner. Be sure to login to save sessions to your schedule.
- Registration Rates and Ticketed Events
Kevin TA Booth, PhD
Laboratory Genetics and Genomics Fellow
Indiana University School of Medicine
Dr. Kevin T.A. Booth is a Laboratory Genetics and Genomics Fellow at the Indiana University School of Medicine. He obtained his undergraduate degree in Chemistry and his Doctor of Philosophy in Molecular Medicine from the University of Iowa. Dr. Booth went on to complete his postdoctoral training at Harvard Medical School, where his research focused on gene therapy for hereditary hearing loss. Dr. Booth has made substantial contributions to our understanding of the genetic, genomic, allelic, and phenotypic landscapes of hereditary hearing loss and the development of gene therapy approaches for genetic hearing loss. Dr. Booth's achievements have been recognized by numerous prestigious awards, including the Rex Montgomery Dissertation Prize in 2019 and the NIH Future Research Leader Award in 2021.
Maria Lalioti, PhD
Scientific Consultant
Pharma and Biotech Industries
Maria is a freelance scientific consultant for drug development in the gene therapy / gene editing space. She obtained her undergraduate degree in Biology from the University of Athens, Greece and her PhD in Human Molecular Genetics from the University of Geneva, Switzerland. She did her postdoctoral training at the University of Birmingham, UK and at Yale School of MedicineShe was an Assistant Professor at Yale doing translational research, before joining the biotech industry, where she served in positions of increasing responsibility (Biogen, Goldfinch Bio, Beam Tx). Her therapeutic areas of expertise include diseases of kidney, liver (metabolic), CNS, and reproductive system. She was an EMBO and HSFP postdoctoral fellow and has received numerous awards for her research including awards from the American and European Societies of Human Genetics (ASHG and ESHG).
Juliann Savatt, MS, CGC
Assistant Professor, Department of Genomic Health
Geisinger
Juliann completed her MS in Genetic Counseling at the University of North Carolina at Greensboro and has practiced as a certified genetic counselor in both cancer and pediatric neurodevelopmental clinical settings. She currently holds the position of Assistant Professor in the Department of Genomic Health at Geisinger where she is involved in multiple research efforts including the Clinical Genome Resource and where she co-directs the Geisinger MyCode Community Health Initiative (MyCode) Genomic Screening and Counseling Program that discloses clinically actionable results to biobank participants.
Beth Sullivan, PhD (Moderator)
James B. Duke Professor of Molecular Genetics and Microbiology
Duke University
Dr. Beth Sullivan is James B. Duke Professor of Molecular Genetics and Microbiology at Duke University and Associate Dean for Research in Duke University School of Medicine. She obtained her undergraduate degree in Biology, Chemistry, and Classics from Western Maryland College (now McDaniel College) and earned her Ph.D. in Human Genetics from the University of Maryland at Baltimore. Her lab studies mechanisms of human genome stability in normal and disease states, with a focus on the genomics and epigenetics of the centromere, functional characterization of alpha satellite DNA variation, and genome engineering of human artificial chromosomes and chromosome rearrangements.